Vibrating mesh nebulisation of pro-antimicrobial peptides for use in cystic fibrosis
É Forde, G Kelly, L Sweeney, D Fitzgerald-Hughes… - Pharmaceutics, 2019 - mdpi.com
Background: There has been considerable interest in the use of antimicrobial peptides
(AMPs) as antimicrobial therapeutics in many conditions including cystic fibrosis (CF). The …
(AMPs) as antimicrobial therapeutics in many conditions including cystic fibrosis (CF). The …
Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit?
DP Nicolau, G Dimopoulos, T Welte… - Expert Review of …, 2016 - Taylor & Francis
Introduction: Pneumonia in the intensive care unit (ICU) is associated with high morbidity,
mortality and healthcare costs. However, treatment outcomes with conventional intravenous …
mortality and healthcare costs. However, treatment outcomes with conventional intravenous …
[引用][C] Assessing new technologies in aerosol medicine: strengths and limitations
A Berlinski - Respiratory Care, 2015 - Respiratory Care